S&P 500 Futures
(0.11%) 5 333.00 points

Dow Jones Futures
(0.04%) 40 155 points

Nasdaq Futures
(0.17%) 18 668 points

Oil
(0.24%) $80.25

Gas
(0.95%) $2.65

Gold
(1.07%) $2 443.20

Silver
(2.85%) $32.15

Platinum
(-0.07%) $1 089.20

USD/EUR
(-0.01%) $0.920

USD/NOK
(-0.07%) $10.67

USD/GBP
(0.08%) $0.788

USD/RUB
(-0.39%) $90.62

Realtime updates for AVROBIO Inc [AVRO]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Last Updated17 May 2024 @ 16:00

25% discount on Stockinvest.us - Use code: Podcast

0.00% $ 1.390

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 16:00):

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide...

Stats
Today's Volume	548 644
Average Volume	225 012
Market Cap	62.40M
EPS	$0 ( 2024-05-09 )
Next earnings date	( $-0.0800 ) 2024-08-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	5.15
ATR14	$0.00500 (0.36%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-14	Leonard Braden Michael	Buy	296 882	Common Stock
2024-05-13	Leonard Braden Michael	Buy	216 053	Common Stock
2024-05-13	Leonard Braden Michael	Buy	253 700	Common Stock
2024-05-13	Leonard Braden Michael	Sell	0	Common Stock
2024-05-13	Leonard Braden Michael	Buy	0	Common Stock

INSIDER POWER
70.40
Last 99 transactions
Buy: 6 444 125 \| Sell: 1 294 974

Volume Correlation

Long: 0.15 (neutral)

Short: -0.83 (strong negative)

Signal:(50.194) Neutral

AVROBIO Inc Correlation

10 Most Positive Correlations
LFUS	0.85
RNRG	0.832
QCLN	0.829
VMAR	0.825
ALTM	0.825
BNGO	0.824
KOSS	0.821
YORW	0.821
UXIN	0.819
OM	0.816

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AVROBIO Inc Correlation - Currency/Commodity

-0.61
( weak negative )

-0.59
( weak negative )

0.00
( neutral )

0.00
( neutral )

0.00
( neutral )

0.66
( moderate )

AVROBIO Inc Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-617 000 (0.00 %)
EPS:	$0.270

FY	2023
Revenue:	$0
Gross Profit:	$-617 000 (0.00 %)
EPS:	$0.270

FY	2022
Revenue:	$0
Gross Profit:	$-4.17M (0.00 %)
EPS:	$-2.42

FY	2021
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-2.78

Financial Reports:

No articles found.

AVROBIO Inc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

AVROBIO Inc

AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the target disease. The company's product includes AVR-RD-01, a gene therapy for the treatment of Fabry disease. It is also developing AVR-RD-02, which is in phase 1/2 clinical trial for the treatment of type 1 Gaucher disease; AVR-RD-03, for the treatment of Pompe disease; AVR-RD-04 for the treatment of cystinosis; AVR-RD-05 for the treatment of Hunter syndrome; and AVR-RD-06 that is in preclinical stage for the treatment of Gaucher disease type 3. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.